Latest News
8 Things to Know About Johnson & Johnson's Janssen COVID-19 Vaccine
As the company announces that its single-dose Janssen COVID-19 Vaccine has been granted Emergency Use Authorization by the U.S. Food and Drug Administration, here are some key facts about how it works (hint: it involves an inactivated common cold virus), how it has been studied, how it would be transported—and more.
Today's Top Reads
Close
-
Did you enjoy reading this story? Click the heart to show your love.
94 -
Did you like reading this story? Click the heart to show your love.
43 -
Did you like reading this story? Click the heart to show your love.
30
Did you like reading this story? Click the heart to show your love.
1211
Learn about the innovative ways the company is mobilizing to help combat the global outbreak caused by the novel coronavirus.
More from Johnson & Johnson
January 25, 2022
Check out this infographic breakdown of the company’s fourth-quarter and annual performance, with highlights from its Consumer Health, Pharmaceutical and Medical Devices businesses.
December 08, 2021
Respiratory syncytial virus (RSV) is normally rampant in winter—but the pandemic has changed the behavior of this common and potentially dangerous infection. Here's how to protect your family this season, and learn how Johnson & Johnson is working to keep us all safer from RSV.
December 07, 2021
Recently honored with two awards for supplier diversity and inclusion, Johnson & Johnson proudly maintains that our differences are our strength, and our diverse culture unleashes our potential.